Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Aryaman Pharmaceuticals Private Limited, is an unlisted private company incorporated on 10 July, 2009. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 1.00 lac and the total paid-up capital is INR 1.00 lac.
The current status of Aryaman Pharmaceuticals Private Limited is - Active.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
8.9%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|---|---|
| Maharashtra | Registered Office | OFF NO 302 A CITY BAY SR NO. A/3C/1 A/1 348 A/1/1 F.P. NA Pune Pune Maharashtra - 411001 |
Locations on Map
Filter (4)
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Prabhakar Supada Palve | 00865732 | 7 years |
| Director | Sulochana Vasant Kankate | 02545108 | 9 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MIRAGE PUBLICITY PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| SUPRA MEDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| SUPRA OUT OF HOME PUBLICITY PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| AMITESH TRADING LLP |
Active
|
10,000.0 | 1 | Maharashtra |
| SOS SUPRA PUBLICITY LLP |
Defunct
|
1.0 L | 1 | Maharashtra |
Severe Risk
Moderate Risk
Low Risk
Read more
The incorporation date of ARYAMAN PHARMACEUTICALS PRIVATE LIMITED is 10 July, 2009
The authorized share capital of ARYAMAN PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of ARYAMAN PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of ARYAMAN PHARMACEUTICALS PRIVATE LIMITED is OFF NO 302 A CITY BAY SR NO. A/3C/1 A/1 348 A/1/1 F.P. NA Pune Pune Maharashtra - 411001
The CIN number of ARYAMAN PHARMACEUTICALS PRIVATE LIMITED is U46497PN2009PTC134298.
Expand
Delete
Collapse
See
details
